Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edward G. Shaw, MD
Wake Forest University Health Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital Medical Center
Sydney, New South Wales, Australia
- Queensland Radium Institute
Herston, Queensland, Australia
- Peter Maccallum Cancer Institute
East Melbourne, Victoria, Australia
- Austin and Repatriation Medical Centre
Heidelberg West, Victoria, Australia
- Academisch Ziekenhuis Der Vrije Universiteit Brussel
Brussels (Bruxelles), Belgium
- Institut Jules Bordet
Brussels (Bruxelles), Belgium
- Uz de Pintelaan
Ghent, Belgium
- U.Z. Gasthuisberg
Leuven, Belgium
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- British Columbia Cancer Agency
Vancouver, British Columbia, Canada
- St. Boniface General Hospital
Winnipeg, Manitoba, Canada
- Newfoundland Cancer Treatment and Research Foundation
St. John's, Newfoundland and Labrador, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Chus-Hopital Fleurimont
Fleurimont, Quebec, Canada
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Centre de Lutte Contre Le Cancer, Georges-Francois Leclerc
Dijon, France
- Chu de la Timone
Marseille, France
- Hopital de Montbeliard
Montbéliard, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Radiologische Uniklink
Freiburg im Breisgau, Germany
- Universitats-Krankenhaus Eppendorf
Hamburg, Germany
- Uzsoki Hospital
Budapest, Hungary
- University of Debrecen
Debrecen, Hungary
- Petz Aladar County Hospital
Gydr, Hungary
- Borsod-Abauj-Zemplen County Hospital
Miskolc, Hungary
- Szeged University
Szeged, Hungary
- Centro Di Riferimento Oncologico - Aviano
Aviano, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Newcastle General Hospital
Newcastle upon Tyne, England, United Kingdom
- Western General Hospital
Edinburgh, Scotland, United Kingdom
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Arizona Cancer Center
Tucson, Arizona, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2000
- Primary completion
- 31 Jan 2003
- Completion
- 31 Jan 2003
- Last update posted
- 23 Aug 2021
- Registered enrollment
- —
- Registry id
- NCT00005887
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.